Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

CTXRCTXR
5 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in CITIUS PHARMACEUTICALS INC

Yes. Two Sigma holds 17,494 shares of CTXR (Citius Pharmaceuticals), worth $10,575, as of its Q2 2026 13F filing. It increased the position by 4,356 shares (+33.2%) from Q1 2026. Two Sigma has held CTXR since Q2 2025, across 5 quarterly 13F filings.

Current Value

$10,575

Current Shares

17,494

Total Value Change

-$9,895

Total Shares Change

+4,620

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
17,494
+33.2%
$10,5750.0%$0.61
15
2026-Q1
Decreased
13,138
-78.4%
$11,8240.0%$0.90
0
2025-Q4
Increased
60,838
+179.0%
$47,2710.0%$0.78
33
2025-Q3
Increased
21,803
+69.4%
$27,0360.0%$1.24
20
2025-Q2
New
12,874
-
$20,4700.0%$1.59
29

Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used